Roselle Herring

8PUBLICATIONS
9CO-AUTHORS
Exercise physiologyMolecular targetsGlobalisation and cultureEpidemiological modellingMedical biotechnology diagnostics (incl. biosensors)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Oct 23, 2022
Effect of Dapagliflozin on Cardiac Function and Metabolic and Hormonal Responses to Exercise.

Roselle A Herring, Iain Parsons, Fariba Shojaee-Moradie

|Mar 21, 2022
The SGLT2 Inhibitor Dapagliflozin Increases the Oxidation of Ingested Fatty Acids to Ketones in Type 2 Diabetes.

Roselle A Herring, Fariba Shojaee-Moradie, Mary Stevenage

|Jul 12, 2021
100 years of physiology, discrimination and wonder.

David Russell-Jones, Roselle Herring

|Feb 20, 2021
Response to Comment on Herring et al. Metabolic Effects of an SGLT2 Inhibitor (Dapagliflozin) During a Period of Acute Insulin Withdrawal and Development of Ketoacidosis in People With Type 1 Diabetes. Diabetes Care 2020;43:2128-2136.

Roselle A Herring, Fariba Shojaee-Moradie, Robert Garesse

|Jul 17, 2020
Effect of Flash Glucose Monitoring on Glycemic Control, Hypoglycemia, Diabetes-Related Distress, and Resource Utilization in the Association of British Clinical Diabetologists (ABCD) Nationwide Audit.

Harshal Deshmukh, Emma G Wilmot, Robert Gregory

|Jul 10, 2020
Metabolic Effects of an SGLT2 Inhibitor (Dapagliflozin) During a Period of Acute Insulin Withdrawal and Development of Ketoacidosis in People With Type 1 Diabetes.

Roselle A Herring, Fariba Shojaee-Moradie, Robert Garesse

Pageof 2

Frequent Collaborators

4 joint publications

David Russell-Jones

1 joint publications

Iain Parsons

1 joint publications

Fariba Shojaee-Moradie

1 joint publications

Ralph Manders